Goldman Sachs’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-212,000
Closed -$6.88M 6703
2025
Q4
$6.88M Buy
212,000
+112,000
+112% +$4.8M ﹤0.01% 3451
2025
Q3
$5.67M Buy
+100,000
New +$5.12M ﹤0.01% 3528

Other funds holding HIMS

Goldman Sachs's HIMS Position: Q1 2026 in Review

Goldman Sachs reduced its Hims & Hers Health (HIMS) stake by 76% in Q1 2026, selling an estimated $186M and leaving 2,454,695 shares worth $51M. The position accounts for 0.01% of the portfolio, ranked #1568.

Goldman Sachs first reported a position in HIMS in Q1 2021 and has held it in 21 quarters since. The position peaked at $523M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Goldman Sachs held 2,454,695 shares of Hims & Hers Health worth $51M as of Q1 2026.
  • Goldman Sachs sold 7,892,648 Hims & Hers Health shares in Q1 2026, an estimated $186M.
  • Hims & Hers Health made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1568 holding.
  • Goldman Sachs first reported a position in Hims & Hers Health in Q1 2021 and has held it in 21 quarters since.
  • Goldman Sachs's Hims & Hers Health position peaked at $523M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.